Do COX-2 inhibitors provide additional pain relief and anti-inflammatory effects in patients with rheumatoid arthritis who are on biological disease-modifying anti-rheumatic drugs and/or corticosteroids? Post-hoc analyses from a randomized clinical trial with etoricoxib

¹ Department of Rheumatology, Diakonhjemmet Hospital, Oslo, N-0319, Vinderen, Norway

² Desert Medical Advances, Palm Desert, CA, USA

³ Clinical Research and Office of the Chief Medical Officer, Merck Co., Inc., Whitehouse Station, NJ, USA

For all author emails, please log on.